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ctivation of PKC depends on the availability of DAG,
a signaling lipid that is tightly and dynamically regu-
lated. DAG kinase (DGK) terminates DAG signaling
by converting it to phosphatidic acid. Here, we demonstrate
that DGK
 
 
 
 inhibits PKC
 
 
 
 activity and that DGK activity is
required for this inhibition. We also show that DGK
 
 
 
 directly
interacts with PKC
 
 
 
 in a signaling complex and that the
binding site in DGK
 
 
 
 is located within the catalytic domain.
Because PKC
 
 
 
 can phosphorylate the myristoylated alanine-
rich C-kinase substrate (MARCKS) motif of DGK
 
 
 
, we tested
A
 
whether this modiﬁcation could affect their interaction. Phos-
phorylation of this motif signiﬁcantly attenuated coimmuno-
precipitation of DGK
 
 
 
 and PKC
 
 
 
 and abolished their
colocalization in cells, indicating that it negatively regulates
binding. Expression of a phosphorylation-mimicking DGK
 
 
 
mutant that was unable to bind PKC
 
 
 
 did not inhibit PKC
 
 
 
activity. Together, our results suggest that DGK
 
 
 
 spatially
regulates PKC
 
 
 
 activity by attenuating local accumulation
of signaling DAG. This regulation is impaired by PKC
 
 
 
-
mediated DGK
 
 
 
 phosphorylation.
 
Introduction
 
DAG is a lipid second messenger that transiently accumulates
in cells stimulated by growth factors and other agonists (Ghosh
et al., 1997; Hodgkin et al., 1998). The best-characterized
role of DAG is as an allosteric activator of PKC (Nishizuka,
1992). The binding of DAG to the C1 domain in PKC induces
an active conformation, allowing the PKC to phosphorylate
its substrates (Newton, 2001). PKCs regulate a broad array
of cell functions, such as growth, differentiation, apoptosis,
and cytoskeletal reorganization (Nishizuka, 1995; Black,
2000; Dempsey et al., 2000). The mammalian PKC family
comprises 10 isoforms divided into three groups: conven-
tional, novel, and atypical (Newton, 1997). By selectively
phosphorylating substrates, each PKC isoform likely mediates a
unique set of cellular functions. This selectivity is dictated in
part by the subcellular targeting of each isoform (Jaken,
1996; Newton, 2001). PKC function is compartmentalized
through interactions with a number of proteins, such as scaffold
proteins, its substrates, and proteins that regulate its activity
(Pawson and Scott, 1997; Jaken and Parker, 2000; Mackay
and Mochly-Rosen, 2001). This compartmentalization allows
precise spatiotemporal activation of PKC, which influences
subsequent signaling events. Because PKC activity depends
on the availability of DAG, the accumulation of DAG in
PKC compartments must be precisely regulated.
DAG kinases (DGKs)* are critical regulators of DAG
signaling. DGKs metabolize DAG by phosphorylating it to
generate phosphatidic acid (PA). To date, nine mammalian
DGK isoforms have been cloned and divided into five
classes based on common structural motifs (Topham and
Prescott, 1999; van Blitterswijk and Houssa, 1999; Kanoh
et al., 2002). Their structural diversity, together with their
different subcellular localization (Topham and Prescott,
1999), suggests that each DGK isoform may regulate distinct
DAG signaling events. DGK
 
 
 
, a type IV DGK, contains a
unique region homologous to the phosphorylation site domain
(PSD) of the myristoylated alanine-rich C-kinase substrate
(MARCKS) protein, a prominent substrate for PKC in cells
(Blackshear, 1993; Bunting et al., 1996). This MARCKS
motif is the predominant nuclear localization signal of
DGK
 
 
 
, and its phosphorylation by PKC isoforms reduces
nuclear localization of DGK
 
 
 
, which alters nuclear DAG
accumulation (Topham et al., 1998). Thus, cells regulate the
concentration of PKC-activating nuclear DAG by controlling
nuclear localization of DGK
 
 
 
. Interestingly, overexpression of
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wild-type DGK
 
 
 
 leads to decreased levels of nuclear DAG
(Topham et al., 1998). This, combined with the fact that
several DAG pools have been found in distinct, spatially
separated compartments within the cell (Wakelam, 1998;
D’Santos et al., 1999), suggests that the regulation of DAG
signaling is achieved locally.
PKC
 
 
 
 is strongly activated by DAG, and its regulation is
likely spatially controlled (Wagner et al., 2000; Newton,
2001). We considered the possibility that DGK
 
 
 
, by metab-
olizing signaling DAG, spatially regulates PKC
 
 
 
 activity.
We demonstrate here that DGK
 
 
 
 associates with PKC
 
 
 
 and
inhibits its activity in a signaling complex. This association
was abolished when the MARCKS motif of DGK
 
 
 
 was
phosphorylated by PKC
 
 
 
. Dissociation of the complex, in
turn, attenuated the inhibition of PKC
 
 
 
 activity; a phos-
phorylation-mimicking DGK
 
 
 
 mutant that could not bind
to PKC
 
 
 
 did not inhibit PKC
 
 
 
 activity. Together, these
data suggest that PKC
 
 
 
 facilitates its own activation by
phosphorylating DGK
 
 
 
. This sequence may allow transient
or even prolonged activation of PKC
 
 
 
 in stimulated cells
while inhibiting its activity in the basal state.
 
Results
 
DGK
 
 
 
 regulates PKC
 
 
 
 activity
 
We previously demonstrated that DGK
 
 
 
 regulates the activ-
ity of Ras guanyl nucleotide–releasing protein (RasGRP)
(Topham and Prescott, 2001), an enzyme that is allosteri-
cally activated by DAG. Because DAG is a crucial compo-
nent of PKC activation, we considered the possibility that
DGK
 
 
 
 could also regulate the enzymatic activity of some
PKC isoforms. PKC
 
 
 
 was an ideal candidate because the
pattern of tissue and cellular expression closely parallels that
of DGK
 
 
 
 (unpublished data). To test this possibility, we
cotransfected PKC
 
 
 
 along with wild-type DGK
 
 
 
 or a mu-
tant, catalytically inactive DGK
 
 
 
 (
 
 
 
ATP) into HEK293
cells and then measured PKC activity in the cell lysates. Ly-
sates from PKC
 
 
 
-transfected cells demonstrated 
 
 
 
10-fold
higher PKC activity than the endogenous PKC activity,
demonstrating that the majority of PKC activity that we
measured was from transfected PKC
 
 
 
 (Fig. 1). We found
that simultaneous expression of DGK
 
 
 
 reduced PKC
 
 
 
 ac-
tivity by 
 
 
 
50% (P 
 
 
 
 0.001), whereas expression of a similar
amount of inactive DGK
 
 
 
 had no significant effect on
PKC
 
 
 
 activity. Thus, DGK activity was required for PKC
 
 
 
inhibition. PA, the product of the DGK
 
 
 
 reaction, did not
affect PKC
 
 
 
 activity (unpublished data), indicating that its
accumulation was not responsible for the inhibition. Sup-
porting our contention that DGK
 
 
 
 regulates PKC
 
 
 
 activity
by converting DAG to PA, we found that DGK
 
 
 
 did not in-
hibit PKC
 
 
 
 activity in the presence of PMA, a DAG ana-
logue that cannot be metabolized by DGK
 
 
 
 (unpublished
data). Demonstrating that the inhibition was selective to
specific PKC isoforms, expression of DGK
 
 
 
 did not affect
PKC
 
 
 
 activity under the same experimental conditions (un-
published data).
 
PKC
 
 
 
 and DGK
 
 
 
 physically associate in the cell
 
Evidence from several laboratories suggests that DGK func-
tion is spatially discrete rather than widespread and random,
suggesting that DGKs specifically regulate a pool of DAG
and the proteins activated by that DAG (van der Bend et al.,
1994; Topham and Prescott, 2001; Kanoh et al., 2002). To
specifically regulate a DAG-activated protein, a DGK iso-
form must closely associate with it. Thus, we hypothesized
that DGK
 
 
 
 may interact with PKC
 
 
 
 in cells. To test this
possibility, we cotransfected HEK293 cells with PKC
 
 
 
 and
DGK
 
 
 
–FLAG and then immunoprecipitated DGK
 
 
 
 with
anti-FLAG antibody. We assayed for coprecipitation of
PKC
 
 
 
 by immunoblotting (Fig. 2 A). In these experiments,
we found that PKC
 
 
 
 clearly coimmunoprecipitated with
DGK
 
 
 
, whereas no PKC
 
 
 
 was detected when we used a non-
immune antibody for the immunoprecipitation. Catalytically
inactive DGK
 
 
 
 (
 
 
 
ATP) still efficiently coimmunoprecipi-
tated with PKC
 
 
 
. This result, combined with the fact that
 
 
 
ATP did not inhibit PKC
 
 
 
 activity (Fig. 1), confirms that
association with PKC
 
 
 
 is not sufficient for DGK
 
 
 
 to inhibit
its activity. Demonstrating the specificity of this interact-
ion, we could not detect coimmunoprecipitation of DGK
 
 
 
and PKC
 
 
 
 under the same experimental conditions (unpub-
lished data). Coimmunoprecipitation cannot distinguish di-
rect from indirect protein–protein interactions. To test whether
DGK
 
 
 
 and PKC
 
 
 
 can directly bind to each other, we exam-
ined their interaction in vitro by incubating purified DGK
 
 
 
–
FLAG immobilized on anti-FLAG beads with recombinant
PKC
 
 
 
. After precipitating the complexes, we observed by
immunoblotting that PKC
 
 
 
 specifically bound to DGK
 
  
 
but
did not bind to control beads (Fig. 2 B). Together, these data
demonstrate that DGK
 
 
 
 and PKC
 
 
 
 interact in vivo and that
they likely bind to each other directly.
Because the above experiments examined the association
of the proteins when they were abundant, which may not
Figure 1. DGK  inhibits PKC  activity in cells. HEK293 cells were 
transfected with PKC  along with a control vector, wild-type (WT) 
DGK , or inactive DGK  ( ATP). After 48 h, the cells were lysed, 
and PKC activity in the cell lysates was measured. Data are expressed 
as the mean   SEM of four independent experiments. An asterisk 
indicates P   0.001 compared with corresponding control value. 
Expression of PKC  and DGK  in the cell lysates of a typical 
experiment is shown in the bottom panel.T
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truly reflect their normal cellular stoichiometry, we tested
whether endogenous DGK  and PKC  could interact in rat
brain extracts. Consistent with our initial results, endoge-
nous PKC  coimmunoprecipitated with DGK  from rat
brain extracts (Fig. 2 C). We could not detect PKC  in im-
munoprecipitates using nonimmune IgG, demonstrating
the specificity of their association. And, consistent with our
results from transfected cells, we did not observe coprecipita-
tion of endogenous DGK  and PKC  in rat brain extracts
(unpublished data). We also tested for binding of endoge-
nous DGK  and PKC  in A172 cells, a glioblastoma cell
line known to express both proteins (Xiao et al., 1994;
Topham et al., 1998). Again, we observed a specific interac-
tion (Fig. 2 D). Together, these data demonstrate that en-
dogenous PKC  and DGK  associate with the same signal-
ing complex in vivo, and that they appear to bind directly to
each other.
A portion of the catalytic domain of DGK  
is sufficient to bind PKC 
To map the domain in DGK  that binds PKC , we exam-
ined a series of DGK  deletion mutants to determine which
ones could associate with PKC . We cotransfected each con-
struct along with PKC  and then immunoprecipitated the
FLAG-tagged DGK  mutant with anti-FLAG antibodies
and assessed coprecipitation of PKC  by immunoblotting.
We found that a region (BD) near the COOH terminus of
the catalytic domain was necessary for PKC  to coprecipi-
tate with DGK  (Fig. 3 A, lane 5). This region (BD), other
than being part of the catalytic domain, lacks any identifiable
protein motifs. Importantly, we also noted in these experi-
ments that two different mutants (L and  M) lacking the
MARCKS motif could still bind PKC  (Fig. 3 A, lanes 6
and 7). This binding in the absence of the MARCKS motif
(the site of PKC  phosphorylation; Topham et al., 1998)
demonstrates that their association was not simply a result of
DGK  being a substrate for PKC .
To determine whether the BD region of DGK  was suffi-
cient to interact with PKC , we incubated recombinant
PKC  with GST fusion proteins containing full-length
DGK  (GST–DGK ), the putative binding domain (GST–
BD), or control GST protein. We assessed coprecipitation of
Figure 2. DGK  and PKC  associate 
with a signaling complex. (A) Lysates 
from HEK293 cells transiently transfected 
with PKC  and vector, FLAG-tagged 
DGK  (WT or  ATP), were immuno-
precipitated using anti-FLAG or a control 
antibody (mouse IgG), and then the 
immunoprecipitates were subjected to 
immunoblot analysis with anti-PKC . 
The blot was then stripped and reprobed 
to detect DGK . Expression of PKC  and 
DGK  in the cell lysates is also shown. (B) Purified PKC  was incubated with purified DGK –FLAG bound to anti–FLAG-M2 agarose affinity 
gel or with affinity gel alone. The beads were washed, and proteins bound to the beads were immunoblotted with anti-PKC . Input represents 
15% of the initial recombinant PKC  used in this experiment. (C) Rat brain extracts were immunoprecipitated with anti-DGK  or a control 
antibody (rabbit IgG), followed by immunoblotting with anti-PKC . The blot was then stripped and reprobed to detect DGK . Expression of 
PKC  and DGK  in the rat brain extracts is also shown. (D) Endogenous DGK  in A172 cell lysates was immunoprecipitated using anti-DGK . 
Normal rabbit IgG was used as a control. The precipitates were subjected to immunoblot analysis with anti-PKC . The blot was then stripped 
and reprobed to detect DGK . Expression of PKC  and DGK  in the A172 cell lysate is shown in the bottom panel.
Figure 3. A portion of the catalytic domain of DGK  is sufficient 
to bind PKC . (A) PKC  was transfected into HEK293 cells along 
with wild-type (WT) DGK  or deletion mutants of DGK  (B, H, X, L, 
 M, and Bsu) containing FLAG epitope tags at their COOH termini. 
DGK  proteins in the cell lysates were immunoprecipitated with 
anti-FLAG or a control antibody (mouse IgG), and coimmuno-
precipitation of PKC  was detected by immunoblotting. The blot 
was then stripped and reprobed with anti-DGK . Because the DGK  
antibody we used was the NH2-terminal anti-peptide rabbit antibody, 
we could not detect the NH2 terminus deletion DGK  mutant L 
(lane 6). However, we detected DGK  L protein in the same blot 
using anti-FLAG antibody (not depicted). Expression of PKC  and 
DGK  in the cell lysates is also shown. (B) Purified recombinant 
PKC  was incubated with the glutathione-sepharose–bound GST 
(lane 1) or GST fusion proteins that contain either full-length DGK  
(GST–DGK , lane 2) or a portion of the catalytic domain of DGK  
(GST–BD, lane 3). The beads were collected by centrifugation, and 
then the proteins bound to beads were subjected to immunoblot 
analysis with anti-PKC . Input represents 5% of initial recombinant 
PKC  used in this experiment.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
932 The Journal of Cell Biology | Volume 160, Number 6, 2003
PKC  by immunoblotting and found that PKC  coprecipi-
tated with both the GST–DGK  and GST–BD fusion pro-
teins, but not with the GST control protein (Fig. 3 B).
Taken together, our results demonstrate that a region in the
COOH terminus of the catalytic domain of DGK  is both
necessary and sufficient to bind to PKC .
Activation of PKC  impairs its association with DGK 
Because activated PKC  regulates the subcellular localiza-
tion of DGK  (Topham et al., 1998), we wondered if the as-
sociation of DGK  and PKC  was similarly dependent on
the activation state of PKC . To assess this possibility,
we examined whether phorbol esters, potent activators of
PKC , affected coprecipitation of DGK  and PKC . Ini-
tially, we monitored the binding between DGK  and PKC 
when both proteins were overexpressed in HEK293 cells
and observed that treating the cells with PMA significantly
reduced coprecipitation of PKC  and DGK  (Fig. 4 A). A
PKC inhibitor abolished this reduction, indicating that
PKC activity was required to attenuate their interaction. To
examine this more directly, we tested whether PMA inhib-
ited in vitro binding of recombinant PKC  and purified
DGK . As demonstrated in Fig. 4 B, the recombinant
PKC  could specifically bind to purified DGK  (lane 2),
but PMA dramatically attenuated their association (lane 1).
To test this in vivo, we used confocal microscopy to examine
whether endogenous DGK  and PKC  colocalized in NIH
3T3 cells and whether PMA had any effect. We found that
the proteins colocalized in the basal state but not after addi-
tion of PMA (Fig. 5). Thus, activation of PKC  inhibits its
association with DGK .
To further examine this, we used A172 cells to test the
effects of a physiologic agonist, PDGF, on the interaction
of endogenous DGK  and PKC . Control A172 cells or
those treated with PDGF were lysed, and then endogenous
PKC  was immunoprecipitated. We then measured DGK
activity in PKC  immunoprecipitates (Fig. 4 C). Under
the experimental conditions, PDGF, which stimulates
PKC  through PLC  (Valius and Kazlauskas, 1993), acti-
vated endogenous PKC  (unpublished data). We found
that PKC  immunoprecipitates had 2.1 times more DGK
activity than control (nonimmune IgG) immunoprecipi-
tates. Stimulation with PDGF almost completely removed
DGK activity from PKC  immunoprecipitates, but not in
the presence of a PKC inhibitor. Thus, activation of PKC 
by PDGF impaired its association with DGK in A172 cells.
Supporting our contention that the associated DGK was
DGK , we found by immunoblotting that PDGF signifi-
cantly attenuated coprecipitation of DGK  and PKC ,
and this was blocked by a PKC  inhibitor (Fig. 4 D).
These data demonstrate that the association between en-
Figure 4. Activation of PKC  impairs its association with DGK . 
(A) HEK293 cells transfected with PKC  and DGK –FLAG were 
stimulated with PMA or vehicle for 30 min. DGK  in the cell lysates 
was immunoprecipitated by anti-FLAG, and coimmunoprecipitation 
of PKC  was detected by immunoblotting. To inhibit PKC activity, 
cells were treated with Gö 6983 for 10 min before PMA stimulation. 
The blot was then stripped and reprobed to detect DGK . Expression 
of DGK  and PKC  in the cell lysates is also shown. (B) Purified 
recombinant PKC  was incubated with purified DGK –FLAG bound to 
anti–FLAG-M2 agarose affinity gel or with affinity gel alone in PKC 
assay buffer (containing phosphatase inhibitors) in the presence or 
absence of PMA. After 2 h, the beads were washed, and proteins 
bound to beads were immunoblotted to detect PKC . Input represents 
5% of the initial recombinant PKC . (C) A172 cells, treated with 
either 50 ng/ml of PDGF or vehicle for 30 min, were lysed, and then 
endogenous PKC  proteins were immunoprecipitated with anti-PKC  
or normal rabbit IgG as a control. The precipitates were then used 
for DGK activity assays. To inhibit PKC activity, the cells were 
treated with Gö 6983 before PDGF stimulation. Data are expressed 
as the mean   SEM of three independent experiments. An asterisk 
indicates P   0.01 compared with corresponding control value. 
(D) PKC  was immunoprecipitated from control or PDGF-treated 
A172 cells as described in the legend to C, and then the precipitates 
were used for immunoblotting with a DGK  antibody to detect 
coimmunoprecipitation of DGK . The blot was then stripped and 
reprobed to detect PKC . Expression of DGK  and PKC  in the cell 
lysates is shown in the bottom.
Figure 5. DGK  and PKC  colocalize in the basal state but not 
after stimulation. Control NIH 3T3 cells or cells treated with PMA 
(90 nM) for 30 min were immunostained to detect DGK  (red) and 
PKC  (green). Confocal images were then obtained to assay for 
colocalization of the proteins. Bar, 10  m.T
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dogenous DGK  and PKC  depends on the activation
state of PKC .
Phosphorylation of the MARCKS motif causes DGK  
and PKC  to dissociate
Because PKC  can phosphorylate the MARCKS motif of
DGK  (Topham et al., 1998), we considered the possibility
that this phosphorylation regulated the association of
DGK  and PKC . Initially, we investigated whether the
MARCKS motif was essential for regulation of their associ-
ation. To test this, we cotransfected HEK293 cells with
PKC  and the MARCKS motif deletion mutant ( M) and
then examined the effect of PMA on the coprecipitation of
PKC  and  M. As shown in Fig. 6 A, treating cells with
PMA did not significantly affect coprecipitation of PKC 
and  M (lane 4) but markedly reduced the binding be-
tween PKC  and wild-type DGK  (lane 2), indicating that
the MARCKS motif was necessary for the binding regula-
tion. Under these experimental conditions, PKC  phos-
phorylated wild-type DGK  on the MARCKS motif upon
PMA stimulation (unpublished data). Thus, these data sug-
gested that phosphorylation of the MARCKS motif inhib-
ited association of DGK  and PKC . To further test this
possibility, we cotransfected HEK293 cells with PKC  and
either wild-type DGK  or a mutant of DGK  in which
serine residues in the MARCKS motif were changed to as-
partates (DGK  S/D) to mimic phosphorylation of these
residues (Swierczynski and Blackshear, 1995; Topham et
al., 1998). We compared the ability of these DGK  proteins
to coimmunoprecipitate PKC . As shown in Fig. 6 B,
DGK  S/D did not interact with PKC  (lane 3), whereas
wild-type DGK  (lane 2) and a second mutant of DGK  in
which the same serines in the MARCKS motif were
changed to asparagines (DGK  S/N) (lane 4) efficiently
coimmunoprecipitated with PKC . These results dem-
onstrated that phosphorylation of the MARCKS motif
by PKC  inhibited the interaction between DGK  and
PKC . To verify this observation, we examined the effect of
PMA on association of PKC  and DGK  S/N. We ex-
pected that activation of PKC  by PMA would not cause
their dissociation because the S/N mutation prevents phos-
phorylation in the MARCKS motif (unpublished data). In-
deed, we found that PMA did not significantly affect copre-
cipitation of PKC  and DGK  S/N (Fig. 6 C).
Phosphorylation-mimicking DGK  does not inhibit 
PKC  activity
Our data indicate the organization of a regulated signaling
complex in which DGK  binds to and locally inhibits PKC 
activity. To extend our observation that phosphorylation of
DGK  caused PKC  and DGK  to dissociate, consequently
relieving PKC  inhibition, we tested whether a mutant
DGK  that could not bind to PKC  could still affect inhibi-
tion of PKC . We transfected HEK293 cells with wild-type
DGK , a mutant DGK  (S/D) that could not bind effi-
ciently to PKC , or another mutant DGK  (S/N) that could
still bind to PKC . After immunoprecipitation of endoge-
nous PKC , we compared its activity in the immunoprecip-
itates. We found in these experiments that expression of
wild-type DGK  significantly reduced endogenous PKC 
activity, consistent with our previous results (Fig. 1), whereas
expression of DGK  S/D did not inhibit endogenous PKC 
activity (Fig. 7, top). Protein expression levels of these
DGK  were similar in these experiments (Fig. 7, bottom).
The lack of inhibition by DGK  S/D was not caused by loss
of its DGK activity, because it demonstrated a high DGK
activity level in the cell lysates (Fig. 7, middle). A control
mutant DGK  S/N also efficiently inhibited endogenous
PKC  in cells, demonstrating that negative charge (i.e.,
phosphorylation) within the MARCKS motif, which causes
dissociation of DGK  and PKC , is necessary to relieve in-
hibition of PKC . Consistent with this, we found that wild-
type DGK  did not inhibit PKC  activity when PMA was
included in the PKC activity reaction (unpublished data).
Taken together, our data demonstrate that DGK  associates
with PKC  to negatively regulate its protein kinase activity.
But, PKC  can relieve this inhibition by phosphorylating
DGK , thus causing dissociation of the two proteins.
Figure 6. Phosphorylation of the 
MARCKS motif induces the dissociation 
between DGK  and PKC . (A) HEK293 
cells transfected with PKC  and either 
wild-type (WT) DGK  or a MARCKS 
deletion mutant ( M). After 48 h, the 
cells were stimulated with PMA or 
vehicle for 30 min. DGK  in the cell 
lysates was immunoprecipitated by 
anti-FLAG, and coimmunoprecipitation 
of PKC  was detected by immunoblotting. 
The blot was then stripped and reprobed 
to detect DGK . Expression of PKC  and 
DGK  in the cell lysates is also shown. 
(B) PKC  was transfected into HEK293 
cells along with wild-type (WT) DGK , DGK  S/D, or DGK  S/N. DGK  proteins in the cell lysates were immunoprecipitated with anti-FLAG 
or a control antibody (mouse IgG), and coimmunoprecipitation of PKC  was detected by immunoblotting. The blot was then stripped and 
reprobed to detect DGK . Expression of PKC  and DGK  in the cell lysates is also shown. (C) HEK293 cells transfected with PKC  and either 
wild-type (WT) DGK  or DGK  S/N were stimulated with PMA or vehicle for 30 min. DGK  in the cell lysates was immunoprecipitated by 
anti-FLAG, and coimmunoprecipitation of PKC  was detected by immunoblotting. To inhibit PKC activity, cells were treated with Gö 6983 
for 10 min before PMA stimulation. The blot was then stripped and reprobed to detect DGK . Expression of DGK  and PKC  in the cell 
lysates is also shown.T
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Discussion
The results presented here demonstrate that DGK  acts to
regulate the activity of PKC . This regulation is accom-
plished by DGK  binding to PKC  and metabolizing local
DAG that would otherwise activate the PKC  enzyme, thus
inhibiting PKC  activity. Indeed, we observed that en-
dogenous DGK  coimmunoprecipitated with endogenous
PKC  in A172 cells and rat brain extracts and that the pro-
teins colocalized in NIH 3T3 cells. In addition, we found
that DGK  directly interacted with PKC . Another finding
confirmed that the regulation of PKC  requires an associa-
tion between DGK  and PKC ; the phosphorylation-mim-
icking DGK  (DGK  S/D) could not bind to PKC  and in-
hibit its activity. Lack of PKC  inhibition by DGK  S/D
likely resulted from its inability to access, and consequently
remove, the local signaling molecule, DAG. Demonstrating
that this inhibition was specific for the PKC  isoform, we
observed that DGK  did not inhibit the activity of PKC ,
another DAG-dependent PKC isoform that did not associ-
ate with DGK . Thus, changes mediated by DGK  in the
concentration of signaling DAG occur locally and may not
affect the function of PKCs found elsewhere within the cell.
Taken together, these data strongly indicate that both the
target (PKC ) and the attenuator (DGK ) of DAG signal-
ing are spatially organized in a signaling complex that is able
to fine tune DAG signaling.
From immunoprecipitation experiments of endogenous
DGK  and PKC , we estimated, using densitometry, that
 10–20% of cellular DGK  coimmunoprecipitated with
 10–20% of cellular PKC  (Fig. 4 D; unpublished data).
Although rough estimates, they correlate well with the
amount of overlap that we observed using confocal micros-
copy and indicate that this regulation affects a subset of cel-
lular PKC . This is not surprising, given the numerous bio-
logic functions of PKC  and the importance of its spatial
regulation, and it suggests that DGK  regulates PKC  in
some, but not all, of its intracellular compartments. Because
of the diverse functions of PKC , the lack of specific PKC 
or DGK  inhibitors, and the absence of direct in vivo PKC 
activity assays, we were unable to determine a distinct physi-
ologic consequence of this regulation. However, we previ-
ously demonstrated a functional association between DGK 
and PKC  in the nucleus, indicating that DGK  may regu-
late signaling mediated by nuclear PKC  (Topham et al.,
1998). In NIH 3T3 cells, though, we found no evidence
that these proteins colocalized in the nucleus (Fig. 5). How-
ever, another DGK  splice variant that is not present in
NIH 3T3 cells predominantly localizes in the nucleus (un-
published data), suggesting that it might regulate nuclear
PKC  activity in cells where it is expressed.
PKC is not the only protein allosterically activated by
DAG; several other proteins, including RasGRP, the chi-
maerins, Unc-13, and protein kinase D (Hurley et al., 1997;
Kazanietz, 2002), have C1 domains and can bind and are ac-
tivated by DAG. We have previously demonstrated (Top-
ham and Prescott, 2001) that RasGRP associated with
DGK  and that DGK  regulated the activation status of
RasGRP by metabolizing local DAG. Additionally, Miller et
al. (1999) and Nurrish et al. (1999) found that a DGK in
Caenorhabditis elegans, an ortholog of mammalian DGK ,
negatively regulated synaptic transmission by metabolizing
DAG that would otherwise activate Unc-13, a protein that is
involved in neurotransmitter secretion. Thus, it appears that
regulation of DAG signaling is frequently spatially restricted
and is achieved through association of DAG target proteins
and DGKs. This may be a common mechanism to regulate
the amplitude or duration of signaling events. Indeed,
Tasken et al. (2001) and Dodge et al. (2001) demonstrated
that phosphodiesterase, which metabolizes cAMP, associated
with PKA, a cAMP-dependent protein kinase, in cells. In
this signaling complex, phosphodiesterase could tightly con-
trol cAMP levels to regulate the activity of PKA and conse-
quently the phosphorylation state of proteins regulated by
PKA. Also, Divecha et al. (2000) observed that phosphati-
dylinositol 4-phosphate 5 kinase interacted with phospholi-
pase D in a signaling complex. It has been shown that the
products of the two enzymes each stimulate the opposite en-
zyme (Jenkins et al., 1994; Exton, 2000). Thus, they pro-
posed a mutual positive regulation, leading to a rapid high
local increase in both products, PA and phosphatidylinositol
4,5-bisphosphate (PIP2), which may be important in a series
of cellular functions. These observations, along with ours,
support a paradigm where regulation of second messengers,
such as DAG, cAMP, and PIP2, is spatially controlled within
an assembled signaling complex.
Increasing evidence suggests that signaling proteins are or-
ganized into localized compartments where regulation of
signaling events can be precisely controlled (Hunter, 2000).
Targeting of protein kinases to the close proximity of their
substrates ensures that they phosphorylate only the proper
targets and prevents inappropriate phosphorylation events
(Pawson and Nash, 2000; Smith and Scott, 2002). PKCs
can directly bind to many substrates, such as adducin,
Figure 7. Phosphorylation of the MARCKS motif of DGK  abolishes 
its inhibitory effect on PKC  activity in cells. HEK293 cells were 
transfected with a control vector, wild-type (WT) DGK , DGK  S/N, 
or DGK  S/D. After 48 h, the cells were lysed, and then endogenous 
PKC  was immunoprecipitated. The immunoprecipitates were used 
for in vitro PKC kinase assays. The DGK activity in the cell lysates 
was also determined using an in vitro DGK kinase assay. The top 
panel shows PKC  activity, and the DGK activity in the cell lysate is 
shown below. The bottom panel shows the protein levels of DGK  
and PKC  in the cell lysates. The data are representative of results 
observed from three independent experiments.T
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GAP43, STICK72, MARCKS, and MARCKS-related pro-
teins (Dekker and Parker, 1997; Jaken and Parker, 2000).
The association of DGK  and PKC , combined with the
fact that PKC  can phosphorylate DGK , suggests that
DGK  is a physiologic substrate for PKC . Interestingly,
we showed that the interaction between DGK  and PKC 
was abolished when PKC  phosphorylated DGK . Jaken’s
group (Chapline et al., 1993; Dong et al., 1995) similarly
demonstrated that adducin bound to PKC and that phos-
phorylation of adducin reduced their interaction. Because
protein phosphorylation often leads to dramatic conforma-
tional changes, phosphorylation of DGK  likely changes its
structure, resulting in its dissociation from PKC . Support-
ing this idea, Bubb et al. (1999) observed a dramatic confor-
mational change when a peptide corresponding to the PSD
of the MARCKS protein was phosphorylated. This struc-
tural change may have resulted from the new negatively
charged phosphates transiently interacting with positively
charged amino acids in the PSD. The new structure was
more compact and caused obliteration of an actin binding
site in the MARCKS protein. The MARCKS motif of
DGK  is homologous to the PSD of the MARCKS protein
(Bunting et al., 1996), so it would not be surprising if phos-
phorylation of the MARCKS motif in DGK  caused similar
conformational changes, resulting in dissociation of DGK 
and PKC . A functional consequence of this phosphoryla-
tion may be to prevent phosphorylated DGK  from access-
ing and removing local DAG that activates PKC .
Our data support a model (Fig. 8) where in the basal state,
when DAG levels in the cell are low, DGK  associates with
and regulates PKC . This allows DGK  to metabolize local
DAG and prevent PKC  activation. Upon stimulation,
when PKC  activity is required, local DAG levels increase
transiently and overcome the ability of DGK  to remove
DAG. Consequently, PKC  becomes activated by DAG
and then phosphorylates DGK , which causes dissociation
of PKC  and DGK . This sequence results in a transient in-
crease in PKC  activity, allowing it to phosphorylate other
substrates. Presumably, PKC  activity is eventually attenu-
ated by a variety of mechanisms, including inactivation of
PLCs, dephosphorylation of PKC  or its proteolytic degra-
dation, and reassociation with DGK . The duration of
PKC  activation likely depends on a variety of circum-
stances, and its regulation is probably complex. Some cellu-
lar responses, such as proliferation and differentiation, re-
quire sustained activation of PKC, whereas other responses
require it to be activated only transiently (Nishizuka, 1995;
Black, 2000). For example, Balciunaite et al. (2000) demon-
strated in HepG2 cells that PDGF stimulated PKC activity
at two distinct times, within 10 min after PDGF treatment
and then for a longer duration, between 5 and 19 h. The late
phase of PKC activity was required for the PDGF-depen-
dent transition from G0 into S phase. Aihara et al. (1991)
found that sustained activation of PKC  is essential for dif-
ferentiation of HL-60 cells to macrophages. Prolonged acti-
vation of PKC  may occur by regulation of DGK  protein
levels, as we have observed that expression of DGK  signifi-
cantly decreases during differentiation of HL-60 cells (un-
published data). We have previously described a functional
correlation of DGK  and PKCs in the nucleus (Topham et
al., 1998), and Shirai et al. (2000) observed that DGK  and
PKC  showed spatially similar, but temporally different,
translocation after purinergic receptor activation in living
cells. They suggested that the time lag between the translo-
cation of DGK  and PKC  may regulate the duration of
PKC  activation. Thus, regulation of conventional PKC
isoforms by DGKs may be a common theme.
In conclusion, we identified a mechanism where DGK , by
metabolizing local DAG, negatively regulates PKC  activity.
In turn, by phosphorylating DGK , PKC  removes this inhi-
bition, allowing its own activation. This mechanism provides
low basal PKC  activity but allows for transient, or even pro-
longed, PKC  activation, depending on the cellular context.
Materials and methods
Materials
PMA, PDGF, phosphatase inhibitor cocktail, and anti–FLAG-M2 agarose
affinity gel were obtained from Sigma-Aldrich. Rabbit polyclonal PKC  an-
tibody, Gö 6983, and human recombinant PKC  (prepared from Sf9 insect
cells) were purchased from Calbiochem. [ -
32P]ATP (6,000 Ci/mmol) was
purchased from Amersham Biosciences. Normal rabbit IgG, normal mouse
IgG–coupled agarose, and protein A/G agarose were from Santa Cruz Bio-
technology, Inc. Glutathione–sepharose 4B was obtained from Amersham
Biosciences. PKC assay kit was purchased from Upstate Biotechnology. Li-
pofectAMINE and all cell culture reagents were obtained from Invitrogen.
Expression plasmids
Wild-type DGK  was cloned into pcDNA1/Amp, and a FLAG epitope tag
was placed at the COOH terminus, as described previously (Topham and
Prescott, 2001). Generation of the progressive COOH-terminal deletions of
DGK  constructs (B, H, and X) has been published previously (Topham and
Prescott, 2001). The NH2-terminal deletion DGK  L was generated by
BamH1 digestion of the DGK –FLAG plasmid followed by religation. For
the DGK  Bsu construct, DGK –FLAG plasmid was digested with Bsu36I
and then religated. The catalytically inactive DGK  mutant ( ATP),
MARCKS motif deletion ( M), and MARCKS motif mutants of DGK  (S/N
and S/D), in which all four serines in the MARCKS motif were altered, were
generated as described previously (Topham et al., 1998). pGEX-5X plasmid
containing wild-type DGK  was a gift from Sarah Leibowitz (Rockefeller
University, New York, NY). GST–BD was generated by cloning a PCR frag-
Figure 8. Model for the spatial regulation between DGK  and 
PKC . In the basal condition, DGK  phosphorylates DAG, thereby 
preventing it from activating PKC . Upon stimulation, local DAG 
levels increase and overcome the ability of DGK  to phosphorylate 
DAG. High levels of DAG activate PKC , which then phosphorylates 
DGK , causing the two proteins to dissociate. This favors transient 
or even prolonged activation of PKC .T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
936 The Journal of Cell Biology | Volume 160, Number 6, 2003
ment comprising nucleotides 1400–1906 of human DGK  into pGEX-5X.
PKC  and PKC  were subcloned into pcDNA3/Amp plasmid (Invitrogen).
Cell culture and transfection
HEK293 and NIH 3T3 cells were maintained in DME containing 10% FBS,
100 U/ml penicillin, and 100  g/ml streptomycin. HEK293 cells were tran-
siently transfected as previously described (Bunting et al., 1996). After 48 h,
the cells were stimulated with 90 nM PMA or vehicle for 30 min. Where in-
dicated, Gö 6983 (500 nM) was added for 10 min before PMA stimulation.
A172 cells were cultured as previously described (Topham et al., 1998).
Preparation of rat brain extracts
Rat brain was homogenized by Dounce homogenizer in lysis buffer (50 mM
Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 10  g/ml
leupeptin, and 10  g/ml aprotinin) containing 1 mM DTT and then centri-
fuged at 100,000 g for 30 min. Cleared lysates were used as brain extracts.
Immunoprecipitation and immunoblotting
FLAG-tagged DGK  was transfected along with PKC  into HEK293 cells.
After 48 h, the cells were harvested in lysis buffer containing phosphatase
inhibitor cocktail (Sigma-Aldrich), allowed to lyse for 30 min on ice, and
then centrifuged to remove debris. 1 ml of cleared lysate (3 mg of total
protein) was incubated with 25  l monoclonal anti–FLAG-M2 agarose af-
finity gel or normal mouse IgG coupled to agarose beads for 2 h. After cen-
trifugation for 5 s at 10,600 g, the beads were washed with 500  l wash
buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl) three times. Immunopre-
cipitates were used for SDS-PAGE. Polyclonal anti-PKC  (Calboichem)
was used to immunoblot for PKC , and DGK  was detected with a previ-
ously described polyclonal DGK  antibody (Topham et al., 1998). To im-
munoprecipitate endogenous DGK  or PKC , A172 cell lysates and rat
brain extracts were precleared with normal rabbit IgG together with pro-
tein A/G agarose for 30 min at 4 C, and then the supernatants were incu-
bated with anti-DGK  or anti-PKC  (Santa Cruz Biotechnology, Inc.) over-
night at 4 C. The immunocomplexes were collected using protein A/G
agarose, washed three times with wash buffer, and then used for immuno-
blotting as described above.
Immunofluorescence and confocal microscopy
NIH 3T3 cells grown on glass coverslips were rinsed in PBS, fixed with 4%
formaldehyde in PBS for 20 min, permeabilized with 0.1% Triton X-100 in
PBS for 10 min, and blocked with PBS containing 5% BSA for 1 h. The
cells were then incubated for 1 h with 1:50 rabbit anti-DGK  antibody and
1:100 mouse anti-PKC  antibody (Transduction Laboratories), followed by
Oregon green–conjugated anti–mouse and Texas red–conjugated anti–
rabbit IgG (Molecular Probes). After being washed with PBS, the immuno-
fluorescently stained cells were imaged using a confocal microscope (Bio-
Rad Laboratories).
In vitro binding assay
DGK –FLAG was expressed in HEK293 cells and immunoprecipitated
with anti–FLAG-M2 agarose affinity gel. The immunoprecipitates were
mixed with purified recombinant PKC  (0.7  g) and incubated for 2 h at
4 C. Then, the beads were washed with wash buffer three times and ana-
lyzed for PKC  binding by immunoblotting. GST–DGK , GST–BD, and
GST proteins were expressed in bacterial strain BL21 and purified by incu-
bation with glutathione–sepharose 4B according to the manufacturer’s in-
structions. The glutathione–sepharose 4B–bound GST fusion proteins were
incubated with purified recombinant PKC  (0.7  g) for 2 h at 4 C. The
beads were washed three times with wash buffer and then used for immu-
noblotting as described above.
Kinase activity assay
PKC  or PKC  was transfected along with a control vector, DGK –FLAG,
or  ATP–FLAG into HEK293 cells. After 48 h, the cells were harvested in
200  l of lysis buffer containing phosphatase inhibitor cocktail. PKC activ-
ity in the cell lysate was determined by a PKC assay kit (Upstate Biotech-
nology) according to the manufacturer’s instructions. To measure en-
dogenous PKC  activity, PKC  proteins from lysates of HEK293 cells
transfected with different DGK  constructs were immunoprecipitated by
polyclonal PKC  antibody (Santa Cruz Biotechnology, Inc.). The PKC  im-
munoprecipitates were collected using protein A/G agarose and washed
three times with wash buffer and once in PKC assay buffer (20 mM MOPS,
pH 7.2, 25 mM  –glycerol phosphate, 1 mM sodium orthovanadate, 1
mM DTT, 1 mM CaCl2). The immunoprecipitate was used for PKC activity
assays. The DGK kinase assay was performed as previously described us-
ing lysates of HEK293 cells transfected with DGK  (Bunting et al., 1996).
1,2-dioleoyl-sn-glycerol was used as the substrate. The reaction was per-
formed for 10 min in the presence of [ -
32P]ATP. Lipids were extracted and
separated by TLC, and PA was visualized by autoradiography.
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